Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
Published on: October 20, 2023
Hypersomnia in Mood Disorders: a Rapidly Changing Landscape
1Department of Psychiatry, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA ; Wisconsin Sleep, 6001 Research Park Blvd., Madison, WI 53719, USA.
Hypersomnia, often seen with depression, can resist treatment. This review covers new classifications, neurobiology, and treatments for hypersomnia in mood disorders, aiming for better diagnosis and therapy.
Area of Science:
- Neuroscience
- Psychiatry
- Sleep Medicine
Background:
- Hypersomnia frequently co-occurs with depressive disorders.
- This comorbidity is linked to treatment resistance, relapse, and impaired functioning.
- Understanding hypersomnia in mood disorders is crucial for effective patient care.
Purpose of the Study:
- To review recent updates in the classification of hypersomnia.
- To summarize emerging research on the neurobiology, assessment, and treatment of hypersomnia in mood disorders.
- To discuss the impact of hypersomnolence on the course of mood illnesses.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of current nosological classifications.
- Synthesis of emergent findings on neurobiology and treatment.
Main Results:
- Recent changes in hypersomnia classification are highlighted.
- Emerging neurobiological findings and assessment strategies are presented.
- The effects of hypersomnolence on mood disorder progression are discussed.
Conclusions:
- Hypersomnia in mood disorders presents unique challenges.
- Further research is needed to understand its causes.
- Improved diagnostic and therapeutic strategies are essential for managing this condition.
More Related Videos
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
06:23A Chronic Sleep Fragmentation Model using Vibrating Orbital Rotor to Induce Cognitive Deficit and Anxiety-Like Behavior in Young Wild-Type Mice
Published on: September 22, 2020
Related Concept Videos
Management of Insomnia
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Insomnia
Multiple factors contribute...
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...